Synthetic Biology Market size is to grow by USD 28,253.12 million from 2022 to 2027, with 42% market growth originating from North America - Technavio

NEW YORK, June 29, 2023 /PRNewswire/ -- The synthetic biology market size is expected to grow by USD 28,253.12 million from 2022 to 2027, progressing at a CAGR of 25.6% as per the latest Technavio market research report. North America is estimated to account for 42% of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In North America,  the market is dominated by the US and Canada. The demand for synthetic biology is anticipated to grow in the region due to factors including, increasing investments in synthetic biology companies, rising demand for bio-based products, and the growing R&D funding for synthetic biology. However, governments in the region are trying to advance the output of the healthcare industry, with a high emphasis on developing personalized therapeutics as well as making high-quality research tools for data reproducibility. Therefore, rising support by private institutions and governments is anticipated to fuel the regional synthetic biology market during the forecast period. For more insights on the market share of various regions- Download a sample report in MINUTES

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial  - buy the report!

Synthetic Biology Market: Growing applications leading to growing adoption of synthetic biology to drive growth

The growing applications of synthetic biology are the major factor driving the synthetic biology market growth. Generally, it helps improve the efficiency of products such as biochemicals, therapeutics, medicine, biofuels, and other bio-based substitutes. Also, it can be used to design genes using genetic engineering in industries such as agriculture and F&B. Moreover, In the future, synthetic biology will be used to develop medicines to fight chronic diseases such as diabetes and cancer. With the rise in the global population, the demand for food is increasing. However, industrialization is leading to a decline in the area of cultivable land and with the help of synthetic technology this issue can be mitigated. Thus, the growing applications of synthetic biology will fuel the global synthetic biology market growth during the forecast period.

Synthetic Biology Market: Evolving Regulatory Framework Around Synthetic Biology 

The evolving regulatory framework around synthetic biology is an emerging trend affecting the synthetic biology market growth. Governments of several nations are working on creating standard policies, clear guidelines, and stringent regulations to tackle the risks associated with synthetic biology. For instance, in the US, the Toxic Substances Control Act (TSCA) deals with the potential human health and environmental impacts of synthetic biology.  Europe has a set of policies at international, community, member state, and local levels. In APAC, many developing countries have not clearly defined synthetic biology, its applications, and its uses. The evolving regulatory framework for synthetic biology is anticipated to facilitate investments, promote innovation, and guarantee the safety and efficacy of synthetic biology products, which, in turn, will support market growth during the forecast period.

To know about more drivers, trends along with challenges - Download a sample now!

Some of the key Synthetic Biology Market Players:

The synthetic biology market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Agilent Technologies Inc., Algenol, Amyris Inc., CD Biosynsis, Codexis Inc., Creative Biogene, Eurofins Scientific SE, Genomatica Inc., GenScript Biotech Corp., Ginkgo Bioworks Holdings Inc., Illumina Inc., Merck KGaA, Novozymes AS, Sanofi SA, Twist Bioscience Corp., Danaher Corp., New England Biolabs Inc., Precigen Inc., Synthego Corp., and Thermo Fisher Scientific Inc.

Synthetic Biology Market: Segmentation Analysis

This market research report segments the synthetic biology market by application (Healthcare, Industrial, Food and agriculture, and Others), product (Oligonucleotides, Enzymes, Cloning technology kits, Xeno-nucleic acids, and Chassis organisms), and geography (North America, Europe, Asia, and Rest of World (ROW)).

• The market share growth by the healthcare segment will be significant during the forecast period. Engineered systems of genes and other molecular components constructed using synthetic biology can help in finding a cure for multiple health issues and increase the efficacy of medical treatments. In the next few years, clinical applications of synthetic biology are expected to grow. Synthetic biology has numerous clinical applications. For instance, professors at the Massachusetts Institute of Technology (MIT) have developed a paper that has embedded modified genetic machinery from a cell. In the UK, scientists have developed a two-step process to synthesize DNA that can be used in biological products. Therefore, the healthcare segment will contribute a significant share to the growth of the global synthetic biology market during the forecast period.

For additional information on the market contribution of each segment - Grab an Exclusive Sample Report

Gain instant access to 17,000+ market research reports

Technavio's SUBSCRIPTION platform

The rapid microbiology testing market size is estimated to grow at a CAGR of 9.31% between 2022 and 2027. The size of the market is forecast to increase by USD 2,487.91 million. This report extensively covers market segmentation by method (growth-based, nucleic-acid-based, viability-based, and others), end-user (hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, and others), and geography (North America, Asia, Europe, and the Rest of World (ROW)). One of the key factors driving the global cancer diagnostics market growth is the high prevalence of cancer. 

The cancer diagnostics market size is estimated to grow at a CAGR of 11.3% between 2022 and 2027. The market size is forecast to increase by USD 12,626.21 million. This report extensively covers market segmentation by end-user (hospitals and clinics, and diagnostic laboratories), type (IVD, imaging, and IDT), and geography (North America, Europe, APAC, and the Rest of the World (ROW)). One of the key factors driving the global cancer diagnostics market growth is the high prevalence of cancer. 

Table of contents

1 Executive Summary

• 1.1 Market Overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022 

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global synthetic biology market 2017 - 2021
• Exhibit 18: Historic Market Size – Data Table on Global synthetic biology market 2017 - 2021 ($ million)

• 4.2 Application Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)

• 4.3 Product Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments 
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Healthcare - Market size and forecast 2022-2027
• Exhibit 34: Chart on Healthcare - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Healthcare - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Healthcare - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Healthcare - Year-over-year growth 2022-2027 (%)

• 6.4 Industrial - Market size and forecast 2022-2027
• Exhibit 38: Chart on Industrial - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Industrial - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Industrial - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Industrial - Year-over-year growth 2022-2027 (%)

• 6.5 Food and agriculture - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Food and agriculture - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Food and agriculture - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Food and agriculture - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Food and agriculture - Year-over-year growth 2022-2027 (%)

• 6.6 Others - Market size and forecast 2022-2027
• Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 6.7 Market opportunity by Application 
• Exhibit 50: Market opportunity by Application ($ million)

7 Market Segmentation by Product

• 7.1 Market segments 
• Exhibit 51: Chart on Product - Market share 2022-2027 (%)
• Exhibit 52: Data Table on Product - Market share 2022-2027 (%)

• 7.2 Comparison by Product 
• Exhibit 53: Chart on Comparison by Product
• Exhibit 54: Data Table on Comparison by Product

• 7.3 Oligonucleotides - Market size and forecast 2022-2027
• Exhibit 55: Chart on Oligonucleotides - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Oligonucleotides - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Oligonucleotides - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Oligonucleotides - Year-over-year growth 2022-2027 (%)

• 7.4 Enzymes - Market size and forecast 2022-2027
• Exhibit 59: Chart on Enzymes - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Enzymes - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Enzymes - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Enzymes - Year-over-year growth 2022-2027 (%)

• 7.5 Cloning technology kits - Market size and forecast 2022-2027 
• Exhibit 63: Chart on Cloning technology kits - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Cloning technology kits - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Cloning technology kits - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Cloning technology kits - Year-over-year growth 2022-2027 (%)

• 7.6 Xeno-nucleic acids - Market size and forecast 2022-2027 
• Exhibit 67: Chart on Xeno-nucleic acids - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Xeno-nucleic acids - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Xeno-nucleic acids - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Xeno-nucleic acids - Year-over-year growth 2022-2027 (%)

• 7.7 Chassis organism - Market size and forecast 2022-2027
• Exhibit 71: Chart on Chassis organism - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Chassis organism - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Chassis organism - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Chassis organism - Year-over-year growth 2022-2027 (%)

• 7.8 Market opportunity by Product 
• Exhibit 75: Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 77: Chart on Market share by geography 2022-2027 (%)
• Exhibit 78: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 79: Chart on Geographic comparison
• Exhibit 80: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 81: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 85: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 89: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 93: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 97: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 UK - Market size and forecast 2022-2027
• Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.9 China - Market size and forecast 2022-2027
• Exhibit 105: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.10 France - Market size and forecast 2022-2027
• Exhibit 109: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 110: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 111: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 112: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.11 Germany - Market size and forecast 2022-2027
• Exhibit 113: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 114: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 115: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 116: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 117: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers 

• 10.2 Market challenges 

• 10.3 Impact of drivers and challenges 
• Exhibit 118: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends 

11 Vendor Landscape

• 11.1 Overview 

• 11.2 Vendor landscape 
• Exhibit 119: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 120: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 121: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 122: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 123: Matrix on vendor position and classification

• 12.3 Agilent Technologies Inc. 
• Exhibit 124: Agilent Technologies Inc. - Overview
• Exhibit 125: Agilent Technologies Inc. - Business segments
• Exhibit 126: Agilent Technologies Inc. - Key news
• Exhibit 127: Agilent Technologies Inc. - Key offerings
• Exhibit 128: Agilent Technologies Inc. - Segment focus

• 12.4 Algenol 
• Exhibit 129: Algenol - Overview
• Exhibit 130: Algenol - Product / Service
• Exhibit 131: Algenol - Key offerings

• 12.5 Amyris Inc. 
• Exhibit 132: Amyris Inc. - Overview
• Exhibit 133: Amyris Inc. - Product / Service
• Exhibit 134: Amyris Inc. - Key offerings

• 12.6 Codexis Inc. 
• Exhibit 135: Codexis Inc. - Overview
• Exhibit 136: Codexis Inc. - Business segments
• Exhibit 137: Codexis Inc. - Key offerings
• Exhibit 138: Codexis Inc. - Segment focus

• 12.7 Danaher Corp. 
• Exhibit 139: Danaher Corp. - Overview
• Exhibit 140: Danaher Corp. - Business segments
• Exhibit 141: Danaher Corp. - Key news
• Exhibit 142: Danaher Corp. - Key offerings
• Exhibit 143: Danaher Corp. - Segment focus

• 12.8 Genomatica Inc. 
• Exhibit 144: Genomatica Inc. - Overview
• Exhibit 145: Genomatica Inc. - Product / Service
• Exhibit 146: Genomatica Inc. - Key offerings

• 12.9 GenScript Biotech Corp. 
• Exhibit 147: GenScript Biotech Corp. - Overview
• Exhibit 148: GenScript Biotech Corp. - Business segments
• Exhibit 149: GenScript Biotech Corp. - Key news
• Exhibit 150: GenScript Biotech Corp. - Key offerings
• Exhibit 151: GenScript Biotech Corp. - Segment focus

• 12.10 Ginkgo Bioworks Holdings Inc.
• Exhibit 152: Ginkgo Bioworks Holdings Inc. - Overview
• Exhibit 153: Ginkgo Bioworks Holdings Inc. - Product / Service
• Exhibit 154: Ginkgo Bioworks Holdings Inc. - Key offerings

• 12.11 Merck KGaA 
• Exhibit 155: Merck KGaA - Overview
• Exhibit 156: Merck KGaA - Business segments
• Exhibit 157: Merck KGaA - Key news
• Exhibit 158: Merck KGaA - Key offerings
• Exhibit 159: Merck KGaA - Segment focus

• 12.12 New England Biolabs Inc. 
• Exhibit 160: New England Biolabs Inc. - Overview
• Exhibit 161: New England Biolabs Inc. - Product / Service
• Exhibit 162: New England Biolabs Inc. - Key offerings

• 12.13 Novozymes AS 
• Exhibit 163: Novozymes AS - Overview
• Exhibit 164: Novozymes AS - Business segments
• Exhibit 165: Novozymes AS - Key news
• Exhibit 166: Novozymes AS - Key offerings
• Exhibit 167: Novozymes AS - Segment focus

• 12.14 Sanofi SA 
• Exhibit 168: Sanofi SA - Overview
• Exhibit 169: Sanofi SA - Business segments
• Exhibit 170: Sanofi SA - Key news
• Exhibit 171: Sanofi SA - Key offerings
• Exhibit 172: Sanofi SA - Segment focus

• 12.15 Synthego Corp. 
• Exhibit 173: Synthego Corp. - Overview
• Exhibit 174: Synthego Corp. - Product / Service
• Exhibit 175: Synthego Corp. - Key offerings

• 12.16 Thermo Fisher Scientific Inc. 
• Exhibit 176: Thermo Fisher Scientific Inc. - Overview
• Exhibit 177: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 178: Thermo Fisher Scientific Inc. - Key news
• Exhibit 179: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 180: Thermo Fisher Scientific Inc. - Segment focus

• 12.17 Twist Bioscience Corp. 
• Exhibit 181: Twist Bioscience Corp. - Overview
• Exhibit 182: Twist Bioscience Corp. - Product / Service
• Exhibit 183: Twist Bioscience Corp. - Key offerings

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 184: Inclusions checklist
• Exhibit 185: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 186: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 187: Research methodology
• Exhibit 188: Validation techniques employed for market sizing
• Exhibit 189: Information sources

• 13.5 List of abbreviations 
• Exhibit 190: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio